Contraceptive Technologies: Looking Ahead to New Approaches to Increase Options for Family Planning.

With persistently high global rates of unintended pregnancy and contraceptive nonuse, nonadherence and discontinuation, new contraceptive methods must address the needs of women and men who seek alternatives to their current options. Methods under development aim to reduce potential side effects, improve access and ease of use, ensure safety, increase secondary benefits associated with method use and expand options for both women and men. Developmental approaches employed to enhance current methods utilize new delivery systems and novel active pharmaceutical ingredients. This will improve overall user satisfaction with the methods used while expanding the number of options available to provide choice and value user autonomy in the highly diverse contraceptive markets around the world.

Strategic partnering to improve community health worker programming and performance: features of a community-health system integrated approach.

BACKGROUND: There is robust evidence that community health workers (CHWs) in low- and middle-income (LMIC) countries can improve their clients' health and well-being. The evidence on proven strategies to enhance and sustain CHW performance at scale, however, is limited. Nevertheless, CHW stakeholders need guidance and new ideas, which can emerge from the recognition that CHWs function at the intersection of two dynamic, overlapping systems - the formal health system and the community. Although each typically supports CHWs, their support is not necessarily strategic, collaborative or coordinated. METHODS: We explore a strategic community health system partnership as one approach to improving CHW programming and performance in countries with or intending to mount large-scale CHW programmes. To identify the components of the approach, we drew on a year-long evidence synthesis exercise on CHW performance, synthesis records, author consultations, documentation on large-scale CHW programmes published after the synthesis and other relevant literature. We also established inclusion and exclusion criteria for the components we considered. We examined as well the challenges and opportunities associated with implementing each component. RESULTS: We identified a minimum package of four strategies that provide opportunities for increased cooperation between communities and health systems and address traditional weaknesses in large-scale CHW programmes, and for which implementation is feasible at sub-national levels over large geographic areas and among vulnerable populations in the greatest need of care. We postulate that the CHW performance benefits resulting from the simultaneous implementation of all four strategies could outweigh those that either the health system or community could produce independently. The strategies are (1) joint ownership and design of CHW programmes, (2) collaborative supervision and constructive feedback, (3) a balanced package of incentives, and (4) a practical monitoring system incorporating data from communities and the health system. CONCLUSIONS: We believe that strategic partnership between communities and health systems on a minimum package of simultaneously implemented strategies offers the potential for accelerating progress in improving CHW performance at scale. Comparative, retrospective and prospective research can confirm the potential of these strategies. More experience and evidence on strategic partnership can contribute to our understanding of how to achieve sustainable progress in health with equity.

A taxonomy and results from a comprehensive review of 28 maternal health voucher programmes.

It is increasingly clear that Millennium Development Goal 4 and 5 will not be achieved in many low- and middle-income countries with the weakest gains among the poor. Recognizing that there are large inequalities in reproductive health outcomes, the post-2015 agenda on universal health coverage will likely generate strategies that target resources where maternal and newborn deaths are the highest. In 2012, the United States Agency for International Development convened an Evidence Summit to review the knowledge and gaps on the utilization of financial incentives to enhance the quality and uptake of maternal healthcare. The goal was to provide donors and governments of the low- and middle-income countries with evidence-informed recommendations on practice, policy, and strategies regarding the use of financial incentives, including vouchers, to enhance the demand and supply of maternal health services. The findings in this paper are intended to guide governments interested in maternal health voucher programmes with recommendations for sustainable implementation and impact. The Evidence Summit undertook a systematic review of five financing strategies. This paper presents the methods and findings for vouchers, building on a taxonomy to catalogue knowledge about voucher programme design and functionality. More than 120 characteristics under five major categories were identified: programme principles (objectives and financing); governance and management; benefits package and beneficiary targeting; providers (contracting and service pricing); and implementation arrangements (marketing, claims processing, and monitoring and evaluation). Among the 28 identified maternal health voucher programmes, common characteristics included: a stated objective to increase the use of services among the means-tested poor; contracted-out programme management; contracting either exclusively private facilities or a mix of public and private providers; prioritizing community-based distribution of vouchers; and tracking individual claims for performance purposes. Maternal voucher programmes differed on whether contracted providers were given training on clinical or administrative issues; whether some form of service verification was undertaken at facility or community-level; and the relative size of programme management costs in the overall programme budget. Evidence suggests voucher programmes can serve populations with national-level impact. Reaching scale depends on whether the voucher programme can: (i) keep management costs low, (ii) induce a large demand-side response among the bottom two quintiles, and (iii) achieve a quality of care that translates a greater number of facility-based deliveries into a reduction in maternal morbidity and mortality.

New strategies for providing hormonal contraception in developing countries.

Even with progress in increasing access to effective contraception over the past decades, and the growing range of contraceptive methods available on the market, women in developing countries continue to report an unmet need for family planning. This constraint continues to challenge reproductive health policies and programs, while the momentum of population growth and the young age structure in developing countries leads to larger numbers of potential contraceptive users and increasing global demand in contraceptive markets. Of late, there is a renewed focus on increasing access to long-acting hormonal methods to effectively meet this need, establishing and effectively implementing new service delivery strategies. A number of processes have profoundly affected the procurement and use of hormonal contraceptive methods in developing countries: a supportive policy environment, evidence-based practices and an increasing diversity of delivery strategies play a significant part in increasing number of contraceptive users and the demand for hormonal contraception.

The changing position of IUDs in reproductive health services in developing countries: opportunities and challenges.

The shared goals of contraceptive development and service delivery efforts are to help individuals and couples achieve their fertility intentions in a healthy, affordable and timely manner. Some would believe that now that contraceptive use has reached 60% in developing countries, there is little need for further investment in product research and development or family planning service delivery for developing countries. The expected growth (40%) in the demand for contraception by 2025 and the prevailing levels of unmet need for contraception (17%) in developing countries suggest that continued efforts to ensure that health systems and donors support family planning services are necessary. The IUD has the potential for enhancing women's health and the ability to both space and limit births at an affordable cost. Organizations involved in product research and development can join with service delivery partners to make new products more accessible to individuals in developing countries.

A question of ethics: research and practice in reproductive health.

The intent of the ethical guidelines and regulations, developed over time, that govern research on human subjects is to ensure that research participants are well-informed volunteers, protected from harm, ensured potential benefit, and enrolled in an egalitarian fashion. This study discusses ethical issues that researchers and program planners grapple with in the area of sexual and reproductive health. We illustrate the dilemmas that arise in the application of the ethical principles, how they have been addressed, lessons learned, and remaining challenges. The illustrations come both from research and from service-delivery situations.

Reproductive behavior in the context of global population.

In 1900, the world's population was estimated at about 1.6 billion. With improved health and a youthful population, the world's total population more than tripled to 6 billion by 1999. There is consensus that the world's population will reach about 8.9 billion by 2050. Despite the persistent growth of population, the reproductive behavior of individuals and couples has changed significantly over the past 50 years with smaller families and lower fertility becoming the norm in many countries. Psychology not only may provide the theoretical frameworks and empirical insights into reproductive behavior but also can foster ways in which the debate on these highly personal issues can be productive for the welfare of people around the world.

La calidad de atención en el mercadeo comercial y social de los programas de planificación familiar en América Latina y el Caribe / La calidad de atención en el mercadeo comercial y social de los programas de planificación familiar en América Latina y el Caribe / Quality of family planning services programs in the Latin American business and social markets

Este artículo revisa la situación de la calidad de atención en el contexto del mercadeo comercial de los productos y servicios de planifiación familiar, con especial enfoque en el desarrollo de programas de mercadeo social de anticonceptivos (MSA) en América Latina y el Caribe (ALC). Se observan los mecanismos comunes a todos los programas de mercadeo del sector comercial, en términos de lo adecuado de su respuesta a las inquietudes sobre la calidad de atención ofrecida por los programas de MSA al proporcionar productos y servicios de planificación familiar

La calidad de atención en el mercadeo comercial y social de los programas de planificacion familiar en América Latina y el Caribe / Quality of family planning services programs in the Latin Américan business and social markets

Este articulo revisa la situación de la calidad de atención en el contexto del mercadeo comercial de los productos y servicios de planificacion familiar, con especial enfoque en el desarrollo de programas de mercadeo social de anticonceptivos (MSA) en América Latina y el Caribe (ALC). Se observan los mecanismos comunes a todos los programas de mercadeo del sector comercial, en terminos de lo adecuado de su respuesta a las inquietudes sobre la calidad de atención ofrecida por los programas de MSA al proporcionar productos y servicios de planificacion familiar